LBPMedicine(SH:688393) Xin Lang Cai Jing·2025-12-31 03:21Group 1 - The core viewpoint of the news is that Anbiping's stock price increased by 1.01% to 24.04 CNY per share, with a total market capitalization of 2.249 billion CNY as of the report date [1] - Anbiping, established on July 6, 2005, and listed on August 20, 2020, specializes in the research, production, and sales of in vitro diagnostic reagents and instruments [1] - The revenue composition of Anbiping includes 79.72% from self-produced products, 13.11% from purchased products, 5.90% from service income, and 1.27% from other sources [1] Group 2 - Longcheng Fund's Longcheng Consumption Value Mixed A Fund (200006) is among the top ten circulating shareholders of Anbiping, holding 850,000 shares, which represents 0.91% of the circulating shares [2] - The Longcheng Consumption Value Mixed A Fund has a current scale of 516 million CNY and has achieved a year-to-date return of 16.56% [2] - The fund's performance ranks 4905 out of 8085 in its category for the year, with a one-year return of 14.6% and a cumulative return since inception of 239.16% [2] Group 3 - The fund manager of Longcheng Consumption Value Mixed A Fund is Long Yufei, who has been in the position for 8 years and 77 days [3] - The total asset size of the fund managed by Long Yufei is 843 million CNY, with the best return during his tenure being 61.42% and the worst being -8.9% [3]